Science • Medicine
2021-01-22T15:00:02+00:00

First long-acting injectable HIV drug combo approved by US FDA

First long-acting injectable HIV drug combo approved by US FDA
Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte. This image has been colored to highlight important features; see PHIL 1197 for original black and white view of this image. Credit: Photo Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManus, Public domain, via Wikimedia Commons

The US Food and Drug Administration (FDA) has approved cabotegravir and rilpivirine injection – called Cabenuva – as a long-acting treatment for HIV-1 infections in adults. The new treatment is the first injectable treatment that has to be administered on a monthly basis, replacing daily pill medications to control the infection of the AIDS virus.

Share
Sources: Content Sources

Source: CBS News

Image Source

Photo Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManus, Public domain, via Wikimedia Commons

Pentributor:
Portrait for @ash
Ashley Winkler
@ash
Highly edible human, designer of all things digital, co-founder of Pendect, creative native, constant wa/onderer, morse code lady, full-time dog pillow.
Card reviewed by: @ericof
Categorization:
Organizations & Institutions
Tags
Category

Science • Medicine